Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Curr Opin Endocrinol Diabetes Obes. 2017 Aug;24(4):285–291. doi: 10.1097/MED.0000000000000348

Figure 3.

Figure 3

Development of diabetes by ECL status. A: All subjects (n = 1,287). B: Subjects positive for one autoantibody by RIAs (n = 902). C: Subjects positive for two or more autoantibodies by RBAs (n = 385). Survival analysis was performed for the development of diabetes since initial visit according to ECL positivity using the log-rank test.

ECL-GADA/ECL-IAA pos, positive for both ECL-GADA and ECL-IAA; ECL-GADA pos, positive for ECL-GADA only; ECL-IAA pos, positive for ECL-IAA only; ECL-GADA/ECL-IAA neg, negative for both ECL-GADA and ECL-IAA.

[13] Diabetes Care. 2016;39:1738–44.